Efgartigimod Promising for Rare Pediatric Disease With Few Treatment Options – Medscape

Written by

admin

in

  1. Efgartigimod Promising for Rare Pediatric Disease With Few Treatment Options  Medscape
  2. Argenx pulls back curtain on Vyvgart trial win as part of mission to ensure ‘no MG patient is left behind’  Fierce Pharma
  3. Myasthenia Gravis Drug Shows Benefits in Wider Range of Patients  MedPage Today
  4. MGFA Session 2025: Vyvgart safe, effective in adolescents with gMG  Myasthenia Gravis News
  5. Efgartigimod Effective in Seronegative gMG, Obexelimab Meets Primary End Point, FDA Accepts NDA for Tau Tracer MK-6240  Neurology Live

Continue Reading

More posts